<VariationArchive RecordType="classified" VariationID="15430" VariationName="NM_000518.5(HBB):c.328del (p.Val110fs)" VariationType="Deletion" Accession="VCV000015430" Version="2" NumberOfSubmissions="2" NumberOfSubmitters="1" DateLastUpdated="2022-09-24" DateCreated="2018-05-09" MostRecentSubmission="2018-05-09">
  <RecordStatus>current</RecordStatus>
  <ReplacedList>
    <Replaced DateChanged="2022-09-24" Accession="VCV000015511" Version="2" VariationID="15511">
      <Comment Type="MergeComment">VCV000015511 was merged into VCV000015430 because the AlleleID created automatically for OMIM was identified to be redundant when the sequence definition of the allelic variant was established.</Comment>
    </Replaced>
  </ReplacedList>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="30469" VariationID="15430">
      <GeneList>
        <Gene Symbol="HBB" FullName="hemoglobin subunit beta" GeneID="3043" HGNC_ID="HGNC:4827" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>11p15.4</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="5225464" stop="5227071" display_start="5225464" display_stop="5227071" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="5246695" stop="5248300" display_start="5246695" display_stop="5248300" Strand="-" />
          </Location>
          <OMIM>141900</OMIM>
        </Gene>
        <Gene Symbol="LOC107133510" FullName="origin of replication at HBB" GeneID="107133510" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>11p15.4</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="5222166" stop="5229620" display_start="5222166" display_stop="5229620" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC110006319" FullName="beta-globin gene 3' regulatory region" GeneID="110006319" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>11p15.4</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="5223780" stop="5226590" display_start="5223780" display_stop="5226590" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_000518.5(HBB):c.328del (p.Val110fs)</Name>
      <CanonicalSPDI>NC_000011.10:5225713:C:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>11p15.4</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="5225714" stop="5225714" display_start="5225714" display_stop="5225714" variantLength="1" positionVCF="5225713" referenceAlleleVCF="AC" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="5246944" stop="5246944" display_start="5246944" display_stop="5246944" variantLength="1" positionVCF="5246943" referenceAlleleVCF="AC" alternateAlleleVCF="A" />
      </Location>
      <OtherNameList>
        <Name>Hb Manhattan</Name>
      </OtherNameList>
      <ProteinChange>V110fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1232" sequenceAccession="LRG_1232">
            <Expression>LRG_1232:g.6358del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1232t1" sequenceAccession="LRG_1232t1">
            <Expression>LRG_1232t1:c.328del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1232p1" sequenceAccession="LRG_1232p1" change="p.Val110fs">
            <Expression>LRG_1232p1:p.Val110fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.10" sequenceAccession="NC_000011" sequenceVersion="10" change="g.5225714del" Assembly="GRCh38">
            <Expression>NC_000011.10:g.5225714del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.5246944del" Assembly="GRCh37">
            <Expression>NC_000011.9:g.5246944del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_000007.3" sequenceAccession="NG_000007" sequenceVersion="3" change="g.71902del">
            <Expression>NG_000007.3:g.71902del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_046672.1" sequenceAccession="NG_046672" sequenceVersion="1" change="g.3649del">
            <Expression>NG_046672.1:g.3649del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_053049.1" sequenceAccession="NG_053049" sequenceVersion="1" change="g.2035del">
            <Expression>NG_053049.1:g.2035del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_059281.1" sequenceAccession="NG_059281" sequenceVersion="1" change="g.6358del">
            <Expression>NG_059281.1:g.6358del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000518.5" sequenceAccession="NM_000518" sequenceVersion="5" change="c.328del" MANESelect="true">
            <Expression>NM_000518.5:c.328del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000509.1" sequenceAccession="NP_000509" sequenceVersion="1" change="p.Val110fs">
            <Expression>NP_000509.1:p.Val110fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="947" DB="HBVAR" />
        <XRef ID="CA125296" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="141900.0340" DB="OMIM" />
        <XRef Type="Allelic variant" ID="141900.0422" DB="OMIM" />
        <XRef Type="rs" ID="63751201" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000518.5(HBB):c.328del (p.Val110fs) AND Beta zero thalassemia" Accession="RCV000016687" Version="28">
        <ClassifiedConditionList TraitSetID="4683">
          <ClassifiedCondition DB="MedGen" ID="C0271980">Beta zero thalassemia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1986-06-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000518.5(HBB):c.328del (p.Val110fs) AND HEMOGLOBIN MANHATTAN" Accession="RCV002284171" Version="1">
        <ClassifiedConditionList TraitSetID="4718">
          <ClassifiedCondition>HEMOGLOBIN MANHATTAN</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2017-12-12" SubmissionCount="1">other</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2017-12-12" NumberOfSubmissions="2" NumberOfSubmitters="1" DateCreated="2018-05-09" MostRecentSubmission="2018-05-09">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic; other</Description>
        <Citation Type="general">
          <ID Source="PubMed">6310991</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">3014870</ID>
        </Citation>
        <DescriptionHistory Dated="2022-09-21">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2022-09-21">
          <Description>other</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="4718" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="11991" Type="NamedProteinVariant">
              <Name>
                <ElementValue Type="Preferred">HEMOGLOBIN MANHATTAN</ElementValue>
                <XRef Type="Allelic variant" ID="141900.0422" DB="OMIM" />
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="4683" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="11956" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Beta zero thalassemia</ElementValue>
                <XRef ID="86715000" DB="SNOMED CT" />
              </Name>
              <XRef ID="C0271980" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="36957" SubmissionDate="2017-12-12" DateLastUpdated="2018-05-09" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="141900.0340_BETA-ZERO-THALASSEMIA" title="HBB, VAL109FS_BETA-ZERO-THALASSEMIA" />
        <ClinVarAccession Accession="SCV000036957" DateUpdated="2018-05-09" DateCreated="2013-04-04" Type="SCV" Version="4" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1986-06-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Frameshift, -G, codon 109, GTG to TG, found in a Lithuanian by Kazazian et al. (1989).</Attribute>
              <Citation>
                <ID Source="PubMed">3014870</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HBB" />
          </GeneList>
          <Name>HBB, VAL109FS</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">VAL109FS</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="141900.0340" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">BETA-ZERO-THALASSEMIA</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="37043" SubmissionDate="2017-12-12" DateLastUpdated="2018-03-25" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="141900.0422_HEMOGLOBIN MANHATTAN" title="HBB, 1-BP DEL, -G, CODON 109_HEMOGLOBIN MANHATTAN" />
        <ClinVarAccession Accession="SCV000037043" DateUpdated="2018-03-25" DateCreated="2013-04-04" Type="SCV" Version="5" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-12-12">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>other</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">As alleles of the HBB gene producing beta-thalassemia were discovered, it became evident that there is a relative paucity of beta-thalassemia mutations in exon 3 of HBB even though this exon accounts for about 30% of the coding region. It appears to be a general rule that 1-bp frameshift mutations and nonsense mutations early in exon 3 produce a chronic hemolytic anemia in the heterozygous state. On the other hand, mutations of this type in exons 1 and 2 in the heterozygous state produce beta-thalassemia trait with mild phenotypic deviations from the normal. Kazazian et al. (1992) reported another example of this rule: in a 78-year-old Lithuanian Ashkenazi Jew with chronic hemolytic anemia, they demonstrated a -1 frameshift (-G) in codon 109. The globin was termed beta-Manhattan for the site of residence of the patient.</Attribute>
              <Citation>
                <ID Source="PubMed">6310991</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HBB" />
          </GeneList>
          <Name>HBB, 1-BP DEL, -G, CODON 109</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, -G, CODON 109</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="141900.0422" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">HEMOGLOBIN MANHATTAN</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="36957" TraitType="Disease" MappingType="Name" MappingValue="BETA-ZERO-THALASSEMIA" MappingRef="Preferred">
        <MedGen CUI="C0271980" Name="Beta zero thalassemia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="37043" TraitType="Disease" MappingType="Name" MappingValue="HEMOGLOBIN MANHATTAN" MappingRef="Preferred">
        <MedGen CUI="C4284922" Name="HEMOGLOBIN MANHATTAN" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

